Xue Wu Song
Director of Finance/CFO at BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD.
Profile
Xue Wu Song is currently working as the VP, Chief Financial & Accounting Officer at Beijing Centergate Technologies (Holding) Co., Ltd.
since 2022.
Additionally, Mr. Song is also a Member-Supervisory Board at DUO Pharmaceutical Co., Ltd.
since 2016.
Mr. Song completed their undergraduate degree at Renmin University of China and their graduate degree at Beihang University.
Xue Wu Song active positions
Companies | Position | Start |
---|---|---|
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD. | Director of Finance/CFO | 25/08/2014 |
DUO Pharmaceutical Co., Ltd.
DUO Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology DUO Pharmaceutical Co., Ltd. is a holding company that engages in the production of pharmaceutical products. It offers medicines in the form of tablets, capsules, injections, and granules. Its products include tramadol hydrochloride tablets and injections, pediatric paracetamol enema, Vitamin C injections, cephalexin and trimethoprim capsules, glucose injections, and lincomycin hydrochloride injections. The company was founded on December 15, 1999 and is headquartered in Jiamusi, China. | Director/Board Member | 07/01/2016 |
Training of Xue Wu Song
Renmin University of China | Undergraduate Degree |
Beihang University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD. | Health Technology |
Private companies | 1 |
---|---|
DUO Pharmaceutical Co., Ltd.
DUO Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology DUO Pharmaceutical Co., Ltd. is a holding company that engages in the production of pharmaceutical products. It offers medicines in the form of tablets, capsules, injections, and granules. Its products include tramadol hydrochloride tablets and injections, pediatric paracetamol enema, Vitamin C injections, cephalexin and trimethoprim capsules, glucose injections, and lincomycin hydrochloride injections. The company was founded on December 15, 1999 and is headquartered in Jiamusi, China. | Health Technology |
- Stock Market
- Insiders
- Xue Wu Song